x

Coronavirus

Johnson & Johnson Testing Vaccine on Teens

NEW BRUNSWICK, N.J. — Johnson & Johnson has started testing its COVID-19 vaccine on adolescents, beginning with those ages 16 and 17.

The teens will be added to an ongoing study of the vaccine in adults that began last September, the New Brunswick, New Jersey-based drugmaker said Friday. After initial data from the older teens is reviewed, the trial will expand to add adolescents ages 12 to 15.

J&J says the first teens are being enrolled in the United Kingdom and Spain. Teens in the United States, Canada and the Netherlands will be added, followed by teens in Brazil and Argentina.

The study is testing the safety and efficacy of both one-dose and two-dose regimens of the vaccine, with the two-dose regimens being studied at intervals of one, two and three months after the first shot.

Dr. Mathai Mammen, global head of research and development for the company’s Janssen pharmaceuticals unit, says it also expects to initiate studies in pregnant women and children.

A total of 100 million J&J doses are pledged for the U.S. by late May or June.

RELATED

BEIJING (AP) — Genetic material collected at a Chinese market near where the first human cases of COVID-19 were identified show raccoon dog DNA comingled with the virus, adding evidence to the theory that the virus originated from animals, not from a lab, international experts say.

Top Stories

Columnists

A pregnant woman was driving in the HOV lane near Dallas.

General News

FALMOUTH, MA – The police in Falmouth have identified the victim in an accident involving a car plunging into the ocean on February 20, NBC10 Boston reported.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.

Video

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. [email protected]

You may unsubscribe at any time using the link in our newsletter.